Wang, Gaowei
Chiou, Joshua http://orcid.org/0000-0002-4618-0647
Zeng, Chun
Miller, Michael
Matta, Ileana
Han, Jee Yun http://orcid.org/0000-0002-4035-7915
Kadakia, Nikita http://orcid.org/0000-0002-1884-1671
Okino, Mei-Lin
Beebe, Elisha
Mallick, Medhavi
Camunas-Soler, Joan http://orcid.org/0000-0001-6148-8132
dos Santos, Theodore http://orcid.org/0000-0002-9761-3609
Dai, Xiao-Qing
Ellis, Cara
Hang, Yan
Kim, Seung K. http://orcid.org/0000-0001-6135-7810
MacDonald, Patrick E.
Kandeel, Fouad R.
Preissl, Sebastian http://orcid.org/0000-0001-8971-5616
Gaulton, Kyle J. http://orcid.org/0000-0003-1318-7161
Sander, Maike
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01DK105541, R01DK122607, R01DK068471, U01DK123716, UC4-DK112217, UC4-DK112232, P30 DK116074, U01DK120447, U01DK123716, U01DK105541, R01DK122607, R01DK114650)
Article History
Received: 23 May 2022
Accepted: 12 April 2023
First Online: 25 May 2023
Competing interests
: K.J.G. holds stock in Vertex Pharmaceuticals and Neurocrine Biosciences. J.C. is now employed by and holds stock in Pfizer Inc. The other authors declare no competing interests.